Understanding Abnormal Blood Chemistry, also known as Irregular Blood Chemistry or Abnormal Blood Test Results, is crucial for accurate clinical documentation and medical coding. This page provides information on interpreting abnormal blood test results, relevant healthcare considerations, and best practices for medical professionals dealing with abnormal blood chemistry findings. Learn about common causes, diagnostic procedures, and the importance of proper documentation for optimal patient care.
Also known as
Abnormal findings on examination of blood
Covers various abnormal blood test results, including chemistry imbalances.
Abnormalities of electrolytes
Relates to electrolyte imbalances found in blood chemistry tests.
Disorders of lipid metabolism
Includes abnormal cholesterol and triglyceride levels often seen in blood chemistry.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the abnormal blood chemistry related to a specific underlying condition?
When to use each related code
| Description |
|---|
| Abnormal blood test results indicating a chemical imbalance. |
| Elevated liver enzymes indicating liver dysfunction. |
| Abnormal kidney function shown by altered blood creatinine and urea nitrogen. |
Coding 'Abnormal Blood Chemistry' lacks specificity. Document the exact abnormal test(s) for accurate coding and billing (e.g., elevated glucose, low potassium).
Insufficient documentation linking 'Abnormal Blood Chemistry' to the patient's condition may lead to coding errors and rejected claims. CDI review needed.
'Abnormal Blood Chemistry' may signal an underlying condition. Further investigation and documentation of a definitive diagnosis are crucial for proper coding.
Q: What are the most common causes of abnormal blood chemistry results in asymptomatic patients, and how should I approach initial investigation?
A: Abnormal blood chemistry results in asymptomatic patients can be caused by a variety of factors, ranging from preanalytical errors (e.g., improper sample collection, storage) and mild, transient deviations to early signs of underlying disease. Common causes include medication side effects (e.g., statins affecting liver enzymes), subclinical infections, vitamin deficiencies (e.g., vitamin D, B12), and early stages of metabolic disorders (e.g., diabetes, hypothyroidism). Initial investigation should focus on reviewing the patient's medical history, medications, and lifestyle factors. Repeat testing is often crucial to confirm persistent abnormalities and rule out preanalytical errors. Targeted follow-up tests based on the specific abnormal analyte(s) should then be considered. For instance, an isolated elevated alkaline phosphatase might warrant further investigation with GGT and bilirubin to assess liver function. Explore how implementing a standardized approach to interpreting abnormal blood tests can improve diagnostic accuracy and patient outcomes. Consider implementing a tiered laboratory testing algorithm to guide efficient and cost-effective investigation.
Q: How can I differentiate between clinically significant abnormal liver function tests (LFTs) and benign, transient elevations in otherwise healthy adults?
A: Differentiating between clinically significant and benign LFT elevations requires careful consideration of the magnitude of the abnormality, the specific LFTs affected (ALT, AST, ALP, GGT, bilirubin), and the patient's overall clinical context. Mild, transient elevations in ALT or AST, often within 2-3 times the upper limit of normal, can be seen in various non-hepatic conditions such as intense exercise, certain medications, and non-alcoholic fatty liver disease (NAFLD). However, persistent or significantly elevated LFTs, especially when accompanied by other symptoms or abnormal findings, warrant further investigation to rule out underlying liver disease. Consider the pattern of LFT abnormalities: a predominantly elevated ALP suggests cholestatic liver disease, while a predominantly elevated ALT and AST suggests hepatocellular injury. Further evaluation might include viral hepatitis serologies, autoimmune markers, imaging studies (ultrasound, MRI), and potentially liver biopsy. Learn more about the utility of non-invasive tests for assessing liver fibrosis in patients with chronic liver disease.
Patient presents today with abnormal blood chemistry, prompting further investigation of potential underlying etiologies. Review of systems and physical exam findings are documented elsewhere. Laboratory results reveal irregularities in the patient's blood test results, indicating an abnormal blood chemistry profile. Differential diagnoses considered include metabolic disorders, renal dysfunction, liver disease, electrolyte imbalance, and nutritional deficiencies. Specific abnormal values are detailed in the laboratory report section of this EHR. Correlation of these laboratory findings with the patient's clinical presentation will guide further diagnostic testing and treatment planning. ICD-10 codes will be assigned based on the definitive diagnosis. The patient was counseled on the significance of these findings, and a plan for follow-up testing and appropriate management strategies was discussed. Patient education materials regarding abnormal blood test results and healthy lifestyle modifications were provided. This case will be reviewed with the attending physician for further recommendations and to ensure appropriate medical coding for billing purposes. Further evaluation and monitoring are warranted to determine the underlying cause of the abnormal blood chemistry and optimize patient care.